Original paper
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate
Abstract
Metformin (MET) is a pharmaceutical with very high use worldwide that is excreted in unchanged form, leading to concern about potential aquatic life impacts associated with MET, and its primary transformation product guanylurea (GUU). This study presents, in two companion papers, a risk assessment following internationally accepted guidelines of MET and GUU in surface water based on literature data, previously unpublished studies, and a new...
Paper Details
Title
Environmental risk assessment of metformin and its transformation product guanylurea. I. Environmental fate
Published Date
Oct 9, 2018
Journal
Volume
216
Pages
844 - 854